Recorded Chinese product: 毒毛花苷K注射液毒毛花苷K注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

毒毛苷k是一种在国家药监局注册认定的药品。标注生产企业为上海信谊金朱药业有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司、上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司、上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 毒毛花苷K注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 上海信谊金朱药业有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司, 上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司, 上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 毒毛花苷K注射液Recorded Chinese product: 毒毛花苷K注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml∶0.25mg1 mL∶0.25 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 上海信谊金朱药业有限公司Chinese legal name: 上海信谊金朱药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31021729

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31021729

Manufacturer

Chinese legal name: 上海信谊金朱药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31021729

生产企业

上海信谊金朱药业有限公司(国产)

适应症

本品适用于急性充血性心力衰竭,特别适用于洋地黄无效的患者,亦可用于心率正常或心率缓慢的心房颤动的急性心力衰竭患者。

用法用量

静脉注射成人常用量:首剂0.125-0.25┦,加入等渗葡萄糖液20-40ml内缓慢注入(时间不少于5分钟),2小时后按需要重复再给一次0.125-0.25┦,总量每天0.25-0.5┦。极量:静脉注射一次0.5┦,一日1┦。病情好转后,可改用洋地黄口服制剂。成人致死量为10┦。小儿常用量:按体重0.007-0.01┦/┧或按体表面积0.3mg/m2,首剂给予一半剂量,其余分成几个相等部分,间隔0.5-2小时给予。

不良反应

1.常见的不良反应包括:新出现的心律失常、胃纳不佳或恶心、呕吐(刺激延髓中枢)、下腹痛、明显的无力、软弱。3.罕见的反应包括:嗜睡、头痛及皮疹、荨麻疹(过敏反应)等。4.中毒表现中,心律失常最重要,最常见为室性早搏,约占心脏不良反应的33%。其次为房室传导阻滞,阵发性或加速性交界区心动过速,阵发性房性心动过速伴房室传导阻滞,室性心动过速、心室颤动、窦性停搏等。儿童中心律失常比其他反应多见,但室性心律失常比成人少见。新生儿可有P-R间期延长。5.皮下注射可以引起局部炎症反应。

禁忌

尚不明确。

注意事项

本品毒性剧烈,过量时可引起严重心律失常。1.近1周内用过洋地黄制剂者,不宜应用,以免中毒危险。2.已用全效量洋地黄者禁用,停药7天后慎用。3.不宜与碱性溶液配伍。4.急性心肌炎、感染性心内膜炎、晚期心肌硬化等患者忌用。5.本品慎用于:(1)低钾血症;(2)不完全性房室传导阻滞;(3)高钙血症;(4)甲状腺功能低下;(5)缺血性心脏病;(6)急性心肌梗死早期;(7)活动性心肌炎;(8)肾功能损害。(9)房、室早搏者。6.皮下注射或肌注可以引起局部炎症反应,一般仅用于静脉注射。7.强心甙中毒,一般会有恶心、呕吐、厌食、头痛、眩晕等,首先应鉴别是由于心功能不全加重,还是强心甙过量所致,因前者需调整剂量,后者则宜停药。8.用药期间忌用钙剂。9.用药期间应注意随访检查:(1)血压、心率及心律;(2)心电图;(3)心功能监测;(4)电解质尤其钾、钙、镁;(5)肾功能;(6)疑有洋地黄中毒时,应作洋地黄血药浓度测定。

贮藏

遮光,密闭保存。

规格

1ml∶0.25mg

证据Evidence

  • 批准文号: 国药准字H31021729
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.